Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nadine Tung, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Smilow Cancer Hospital Care Center at Derby
Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center at Guilford
Guilford, Connecticut, United States
- St. Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Yale School of Medicine
New Haven, Connecticut, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Duke University
Durham, North Carolina, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 May 2019
- Completion
- 2 Feb 2025
- Last update posted
- 5 May 2026
- Registered enrollment
- 118
- Registry id
- NCT01670500
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.